The Budget will obviously be crucial. But US President Donald Trump may have even more of an influence than Finance Minister Arun Jaitley when it comes to sentiment, argues Devangshu Datta.
Part of landing your dream job involves knowing the ins and outs of that particular job.
Covering-up of short positions ahead of Thursday's expiry of August series in the derivatives segment gave equities a slight push
Sun Pharma was the best gainer among Sensex components, surging 6.91 per cent
Samvat 2072: Auto sector could see faster recovery
'We have to plan for whatever the new normal is.'
Indian auto industry's dependence on China is high and it will continue to be so in the BS-VI era and as the country moves towards electric mobility. Domestic players lack both technological competence and the sheer pricing advantage that support Chinese imports.
Six months after the Paras deal, Actis wants to exit Sterling Hospitals, a Gujarat-based multi-speciality hospital chain with six centres, according to three independent sources in the know.
After healthcare and frontline workers, priority will be given to those above 50 years of age and the under-50 population groups with co-morbidities numbering around 27 crore, it added.
'China feels India will be hard-pressed not to go after China because we are so badly dependent on them -- and that is the reality.'
In an email interview, the Mumbai-based Devdutt Pattanaik spoke to redidff.com about his latest book on the Mahabharata and about what lessons the epic holds for today's times
PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.
India is currently under the 21-day lockdown since March 25, with only essential services exempted to contain the fast-spreading virus.
Amazon committed a fresh investment of $3 billion, in addition to the $2 billion it announced in 2014.
Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.
World Anti-Doping Agency (WADA) moves fast, but one thing is clear drug cheats and pharma companies helping them break records are definitely faster than WADA.
Tata Motors was the worst performer on the Sensex, plummeting 10.32 per cent to Rs 436.55 after the company reported a steep 96.22 per cent decline in consolidated net profit for the December quarter.
The value of mergers and acquisitions that India Inc snapped up in the first half of the year surged over seven times to a staggering $38 billion or over Rs 1.8 trillion, led by big ticket deals in the telecom and pharma sectors.
Companies such as Cadila Healthcare, Lupin, and Natco, which sell generic versions of flu medication in the US market, are likely to benefit.
In the second of our three-part series on entrepreneurs who made it big without an MBA taken from author Rashmi Bansal's book Connect the Dots, we publish excerpts from Chetan Maini (of Reva Electric Car Company) and Samar Gupta's (of Trikaya Agriculture) stories.
After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set out to bring the house in order.
'We have seen a host of businesses across sectors generate economic value and wealth for investors.'
Any concerned citizen ought to start practicing hygiene by washing their hands properly and be aware of the brands that are certified.
'China need not worry about a truly 'resurgent India'.' 'It's not going to happen.'
It was an extremely volatile session, borne out by the Sensex swinging over 1,200 points through the day and the Nifty 369 points.
Gaurav Garg, Head of Research, CapitalVia answers readers' stock market queries
Piramal Enterprises has about Rs 10,000 crore (Rs 100 billion) cash on its books.
Nothing is going to dramatically open up on May 3. There will be too many ifs and buts and terms and conditions and guidelines in leading one's life in various zones, reveals Sheela Bhatt.
Interacting with state chief ministers, Modi underscored the enormity of what he described as the world's biggest vaccination exercise, which begins from January 16, saying over 30 crore citizens will get the jabs in the next few months in India against only 2.5 crore people vaccinated so far in over 50 countries in around a month.
The BSE benchmark Sensex surged about 241 points to end at 35,165.48 and the NSE Nifty gained 84 points to close at 10,688.65.
'Investors need to diversify at least 30% to 50% of their liquid wealth across different markets, asset classes, and instruments across the world.' 'Do this with proper guidance and advice.' 'Global investing is complicated, but if done right, is extremely rewarding.'
Pharma stocks have performed well after Budget
Sun Pharma on Thursday threatened legal action against Israel's $313 million Taro Pharmaceuticals, which unilaterally terminated a $454 million all-cash merger deal on Wednesday that would have catapulted the Rs 2404 crore Indian firm into the big league.
To address the supply crunch, CII has suggested leveraging the existing excess capacity in the Indian industry; rolling back import duty hike to look for alternative sources of imports; expanding credit to manufacturing units with quick loan sanctions, and one-time emergency waiver of non-performing asset regulations for three months.
A large number of American companies like Google, Uber and IBM are offering their resources to help India successfully fight the battle against the deadly coronavirus pandemic.
Analysts feel this decision is yet another example of big-ticket acquisitions turning sour for Indian pharma firms, as happened in the case of Dr Reddy's acquisition of Betapharm of Germany for Rs 2,250 crore (Rs 22.5 billion).
'A bit of marketing, a bit of positioning, and a lot of strategic thinking is required, and all this should be in aid of India's strategic intent: Becoming the third pole in a global G3 and aiming for Numero Uno,' says Rajeev Srinivasan.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The list includes Hindustan Unilever, Asian Paints and Bharti Airtel - firms that investors feel are most likely to come up with the next big innovation.
Corporate India's earnings in the past two quarters were largely driven by the rupee's sharp fall versus the dollar in the second quarter of this financial year.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances